Phase II trial of S‐1 treatment as palliative‐intent chemotherapy for previously treated advanced thymic carcinoma-Reference-Cited by-同舟云学术

Phase II trial of S‐1 treatment as palliative‐intent chemotherapy for previously treated advanced thymic carcinoma

Published:2020-08-19 Issue:20 Volume:9 Page:7418-7427
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Okuma Yusuke¹²^ORCID,Goto Yasushi²^ORCID,Ohyanagi Fumiyoshi³⁴,Sunami Kuniko⁵,Nakahara Yoshiro¹⁶,Kitazono Satoru³^ORCID,Kudo Keita³⁷,Tambo Yuichi³⁸^ORCID,Kanda Shintaro²,Yanagitani Noriko³,Horiike Atsushi³⁹,Horinouchi Hidehito²^ORCID,Fujiwara Yutaka²¹⁰^ORCID,Nokihara Hiroshi²¹¹,Yamamoto Noboru²,Nishio Makoto³^ORCID,Ohe Yuichiro²^ORCID,Hosomi Yukio¹

Affiliation:

1. Department of Thoracic Oncology and Respiratory Medicine Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital Tokyo Japan

2. Department of Thoracic Oncology National Cancer Center Hospital Tokyo Japan

3. Department of Thoracic Medical Oncology The Cancer Institute Hospital of Japanese Foundation for Cancer Research Tokyo Japan

4. Division of Pulmonary Medicine Clinical Department of Internal Medicine Jichi Medical University Saitama Medical Center Saitama Japan

5. Department of Pathology and Clinical Laboratories National Cancer Center Hospital Tokyo Japan

6. Department of Thoracic Oncology Kanagawa Cancer Center Yokohama Japan

7. Department of Thoracic Medical Oncology National Hospital Organization Osaka Minami Medical Center Osaka Japan

8. Respiratory Medicine Kanazawa University Ishikawa Japan

9. Division of Medical Oncology Department of Medicine Showa University School of Medicine Tokyo Japan

10. Department of Respiratory Medicine Mitsui Memorial Hospital Tokyo Japan

11. Department of Respiratory Medicine and Rheumatology Graduate School of Biomedical Sciences Tokushima University Tokushima Japan

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.3385

Reference38 articles.

1. Rare cancers: work in progress in Europe

2. Rare cancers are not so rare: The rare cancer burden in Europe

3. Rare Cancers Europe.https://www.rarecancerseurope.org/. Accessed August 10 2020.

4. Rare Cancers Europe (RCE) methodological recommendations for clinical studies in rare cancers: a European consensus position paper

5. Thymic epithelial tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thymic epithelial tumor medical treatment: A narrative review;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

2. Clinical Characteristics of 34 Cases Diagnosed as Thymic Carcinoma in Our Institution;Haigan;2024-08-20

3. Comparison of Efficacy and Safety of Different Second-line Therapies for Patients With Advanced Thymic Carcinoma;Clinical Oncology;2024-04

4. Current Treatment Approaches for Thymic Epithelial Tumors;Life;2023-05-12

5. The Diagnosis and Multimodality Treatment of Malignant Mediastinal Tumors;Haigan;2023-04-20